Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 2/20 | 0.36 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL830579 | 1.00 | LMNA (0.43) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL428372 | 1.00 | LMNA (0.43) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL424124 | 1.00 | — | — | |
| SCHEMBL13202549 | 1.00 | LMNA (0.43) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL19411359 | 1.00 | LMNA (0.43) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| 1,6-Hexanediol SCHEMBL15347446 | 1.00 | LMNA (0.43) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL554360 | 1.00 | LMNA (0.43) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL10406986 | 1.00 | LMNA (0.43) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL5398466 | 1.00 | LMNA (0.43) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL12491774 | 1.00 | LMNA (0.43) | LMNATSHRALDH1A1HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225822-B1 | METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING DIOL CONTAINING FORMULATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2026-05-13 | — | — | EP | disclosed |
| US-20260070270-A1 | COMPOSITION, MOLDED BODY, AND METHOD FOR PRODUCING COMPOSITION | FUJIFILM CORPORATION (JP) | 2026-03-12 | — | — | US | disclosed |
| WO-2024257548-A1 | COMPOSITION, MOLDED BODY, AND METHOD FOR PRODUCING COMPOSITION | 富士フイルム株式会社 | 2024-12-19 | — | — | WO | disclosed |
| EP-4463534-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | The Procter & Gamble Company (US) | 2024-11-20 | — | — | EP | disclosed |
| US-20230416446-A1 | Method for Producing Polyurethane Foams or Hydrogels by Employing Diol Containing Formulations | COVESTRO DEUTSCHLAND AG (DE) | 2023-12-28 | — | — | US | disclosed |
| CN-116981709-A | Method for producing polyurethane foam or hydrogel by using diol-containing formulation | 科思创德国股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-4225822-A1 | METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING DIOL CONTAINING FORMULATIONS | Covestro Deutschland AG (DE) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023137409-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | THE PROCTER & GAMBLE COMPANY (US) | 2023-07-20 | — | — | WO | disclosed |
| US-20230220300-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | THE PROCTER & GAMBLE COMPANY | 2023-07-13 | — | — | US | disclosed |
| EP-3995522-A1 | METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING DIOL CONTAINING FORMULATIONS | Covestro LLC (US) | 2022-05-11 | — | — | EP | disclosed |
| CN-113195547-A | Photocurable composition for imprinting | 日产化学株式会社 | 2021-07-30 | — | — | CN | disclosed |
| WO-2020213373-A1 | PHOTOCURABLE COMPOSITION FOR IMPRINT | 日産化学株式会社 | 2020-10-22 | — | — | WO | disclosed |
| EP-2686366-B1 | BIO-BASED POLYESTER LATEX | OCE TECH BV (NL) | 2019-12-25 | — | — | EP | disclosed |
| US-9068091-B2 | Bio-based polyester latex | OCE TECHNOLOGIES B.V. (NL) | 2015-06-30 | — | — | US | disclosed |
| EP-2686366-A1 | BIO-BASED POLYESTER LATEX | OCE-Technologies B.V. (NL) | 2014-01-22 | — | — | EP | disclosed |
| WO-2012123267-A1 | BIO-BASED POLYESTER LATEX | OCE-TECHNOLOGIES B.V. (NL) | 2012-09-20 | — | — | WO | disclosed |
| US-6121270-A | N-(EPOXYALKYL)XANTHINE DERIVATIVES WHICH MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI | CELL THERAPEUTICS, INC. (US) | 2000-09-19 | — | — | US | disclosed |
| US-5866576-A | COMPOUNDS THAT ACT AS DRUGS ON THE CELLULAR AND BIOCHEMICAL LEVEL TO MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI. | CELL THERAPEUTICS, INC. (US) | 1999-02-02 | — | — | US | disclosed |
| US-4618724-A | Perfluorocarbon polymer oxidation catalyst and preparation of carbonyl compound | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-10-21 | — | — | US | disclosed |
| US-4617153-A | PERFLUOROCARBON POLYMER CONTAINING DIFLUOROMETHYLENE CHROMIUM SULFONYL PENDANT GROUPS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070270-A1 | COMPOSITION, MOLDED BODY, AND METHOD FOR PRODUCING COMPOSITION | TES, MTPN, ALG3 | LMNA 1351/4885TSHR 4055/4885ALDH1A1 2967/4885 |
| US-20230220300-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | BCAT2, MTR, ASNS | LMNA 793/4885TSHR 4858/4885ALDH1A1 3811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.